Navigation Links
Common Respiratory Diseases Tied to Lung Cancer Risk
Date:8/15/2014

FRIDAY, Aug. 15, 2014 (HealthDay News) -- Three common respiratory diseases seem to be associated with an increased risk of lung cancer, researchers report.

The investigators analyzed data from seven studies that included more than 25,000 people and found that chronic bronchitis, emphysema and pneumonia were linked with a greater risk of developing lung cancer.

Having asthma or tuberculosis was not associated with a higher lung cancer risk, according to the study published in the Aug. 15 issue of the American Journal of Respiratory and Critical Care Medicine.

People who had all three -- chronic bronchitis, emphysema and pneumonia -- had a higher risk of lung cancer than those with chronic bronchitis only. There was no increased risk of lung cancer among those who had chronic bronchitis along with asthma or tuberculosis, the study found.

In a journal news release, study author Ann Olsson said the reason respiratory illnesses may affect lung cancer risk in different ways could have to do with underlying disease mechanisms.

A better understanding of the links between respiratory ailments and lung cancer may help inform doctors on how best to monitor and help patients, said Olsson, of the International Agency for Research in Cancer in Lyon, France.

Although the study found an association between certain respiratory diseases and lung cancer risk, it did not prove a cause-and-effect relationship.

More information

The U.S. National Library of Medicine has more about lung cancer.

SOURCES: American Journal of Respiratory and Critical Care Medicine, news release, Aug. 15, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Texting in College Classrooms Common, Distracting
2. Recovery from propofol anesthesia may be sped by use of common stimulant
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Overuse Injuries Common Among Female College Athletes
5. Common Blood Pressure Drug Safe for Heart Failure: Study
6. Test links strains of common parasite to severe illness in US newborns
7. Common Plastics Chemical Might Boost Diabetes Risk
8. Off-Label Drug Use Appears Common
9. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
10. Slow-growing babies more likely in normal-weight women; Less common in obese pregnancies
11. Common Blood Pressure Drugs May Not Cut Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Respiratory Diseases Tied to Lung Cancer Risk
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: